Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anaferon for Children for Prevention of Influenza/ARVI
NCT03301155Phase 4Completed
- Sponsor
- Materia Medica Holding
- Start
- Oct 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of anaferon in influenza, acute respiratory viral infection (ARVI), sponsored by Materia Medica Holding. Started Oct 2017; status: completed.
02
Drugs
anaferon
03
Conditions
influenzaacute respiratory viral infection (ARVI)
Beyond the preview
Go deeper on NCT03301155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03301155.